Close

Schreiner MediPharm Develops Novel Cut-Through Indicator for Closure Seals

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Key steps to bring ADCs successfully to clinical trial

The use of antibody-drug-conjugates (ADC) in drug development is...

Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS)

Zydus, a leading, discovery-based, global pharmaceutical company today announced...

Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris

Live from Porte De Versailles, Paris: Pharmapack Europe 2025 (January...

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy™ reusable electromechanical...

Blauvelt, NY – Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has introduced a cut-through indicator functionality for closure seals that makes tampering attempts clearly visible. The solution’s special design enables flexible integration of the security feature, offering an effective and cost-efficient solution for product protection, and helping to secure the broader pharmaceutical supply chain.

The new cut-through indicator function leaves any attempt at tampering readily and irreversibly apparent. This approach effectively prevents, for example, the frequently used method of tampering with folding boxes by cutting open the seal and reapplying it with transparent adhesive tape.

Schreiner MediPharm’s cut-through indicator function is not designed as a standardized label, but rather as a modular feature that can be integrated individually into existing or newly developed closure seals. This means that the cut-through indicator function is customized to suit the respective seal and specific application. The single-layer structure enables flexible and cost-efficient adaptation to various materials and customer-specific designs. In addition, the function satisfies the highest security requirements for pharmaceutical packaging according to ISO 21976, and the European Falsified Medicines Directive 2011/62/EU.

Featuring thin, long, highly flexible strips, the solution’s particularly conspicuous die-cutting contours make lateral shifting or defects caused by tampering attempts plainly visible. Security features such as raised structures and irregular outer contours can also be integrated to further enhance the protective effect. Likewise, special graphic design options can be incorporated – for instance, guilloches as an added authentication feature.

Drugs that have been faked or tampered with pose considerable risks both to patient health and to the reputations of pharmaceutical companies. The new cut-through indicator function exemplifies Schreiner MediPharm’s commitment to supporting the integrity of the pharmaceutical supply chain.

Schreiner MediPharm
Company Logo

Latest stories